Becton, Dickinson & Co. (BDX)
184.74
-2.88
(-1.54%)
USD |
NYSE |
Sep 04, 16:00
185.00
+0.26
(+0.14%)
Pre-Market: 20:00
Becton, Dickinson Research and Development Expense (Quarterly) : 258.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 258.00M |
| March 31, 2026 | 249.00M |
| December 31, 2025 | 306.00M |
| September 30, 2025 | 322.00M |
| June 30, 2025 | 230.00M |
| March 31, 2025 | 232.00M |
| December 31, 2024 | 343.00M |
| September 30, 2024 | 302.00M |
| June 30, 2024 | 299.00M |
| March 31, 2024 | 299.00M |
| December 31, 2023 | 290.00M |
| September 30, 2023 | 281.00M |
| June 30, 2023 | 306.00M |
| March 31, 2023 | 337.00M |
| December 31, 2022 | 313.00M |
| September 30, 2022 | 300.00M |
| June 30, 2022 | 315.00M |
| March 31, 2022 | 343.00M |
| December 31, 2021 | 314.00M |
| September 30, 2021 | 368.00M |
| June 30, 2021 | 330.00M |
| March 31, 2021 | 317.00M |
| December 31, 2020 | 291.00M |
| September 30, 2020 | 299.00M |
| June 30, 2020 | 262.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 264.00M |
| December 31, 2019 | 270.00M |
| September 30, 2019 | 270.00M |
| June 30, 2019 | 282.00M |
| March 31, 2019 | 252.00M |
| December 31, 2018 | 258.00M |
| September 30, 2018 | 277.00M |
| June 30, 2018 | 277.00M |
| March 31, 2018 | 259.00M |
| December 31, 2017 | 192.00M |
| September 30, 2017 | 221.00M |
| June 30, 2017 | 186.00M |
| March 31, 2017 | 187.00M |
| December 31, 2016 | 182.00M |
| September 30, 2016 | 253.00M |
| June 30, 2016 | 207.00M |
| March 31, 2016 | 182.00M |
| December 31, 2015 | 187.00M |
| September 30, 2015 | 196.00M |
| June 30, 2015 | 178.00M |
| March 31, 2015 | 129.00M |
| December 31, 2014 | 129.00M |
| September 30, 2014 | 134.00M |
| June 30, 2014 | 128.00M |
| March 31, 2014 | 127.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 892.00M |
| Boston Scientific Corp. | 554.00M |
| Stryker Corp. | 424.00M |
| Baxter International, Inc. | 125.00M |
| DexCom, Inc. | 153.00M |